These university press releases are designed to project institutional value. They are not proof of what the institution has delivered or why it deserves continued public funding. Even if this work proves valuable, and I remain skeptical, nothing here explains why the funding needed to be concentrated at Harvard. That concentration is the product of a legacy NIH system that repeatedly sends public money to the same institutions. NIH should change its priorities and redirect future funding as science and public interests change. Harvard has no permanent entitlement to federal research money simply because it benefited from the previous system.